DONG-A ST CO.,LTD (동아에스티(주))
KOSPI Stock Code: 170900 | DART Corp Code: 00956930
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | DONG-A ST CO.,LTD |
|---|---|
| Korean legal name | 동아에스티(주) |
| Alternate names | 동아에스티 |
| Market | KOSPI |
| Stock Code | 170900 |
| DART Corp Code | 00956930 |
| CEO | 정재훈 |
| Business Registration No. | 2048640122 |
| Corporate Registration No. | 1101115079713 |
| Established Date | 2013-03-04 |
| Fiscal Month | 12 |
| KSIC Industry Code | 212 |
| Address (KO) | 서울 동대문구 용두동 138 ~255 천호대로 64 |
| Homepage | https://www.donga.co.kr/ |
| source_url | https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001313 |
| verified_at | 2026-11-01T02:26:13.029Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001313
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 808,780,057,197 | KRW 697,869,071,451 |
| Operating Income (영업이익) | KRW 623,189,224 | KRW -25,002,030,853 |
| Net Income (당기순이익) | KRW -37,611,298,405 | KRW -23,234,979,865 |
| Total Assets (자산총계) | KRW 1,412,046,030,981 | KRW 1,391,734,505,157 |
| Total Liabilities (부채총계) | KRW 740,397,480,634 | KRW 682,926,806,770 |
| Total Equity (자본총계) | KRW 671,648,550,347 | KRW 708,807,698,387 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-30 | 20261030800910 | Material Business Matters Related to Investment Decisions (제2형 당뇨병 치료 복합제 슈가엠파정 국내 품목허가 승인) | 투자판단관련주요경영사항 (제2형 당뇨병 치료 복합제 슈가엠파정 국내 품목허가 승인) | 동아에스티 |
2026-10-27 | 20261027800221 | Organization of Investor Relations Event | 기업설명회(IR)개최(안내공시) | 동아에스티 |
2026-10-27 | 20261027800159 | Interim Report on Business Performance (Fair Disclosure) | 영업(잠정)실적(공정공시) | 동아에스티 |
2026-10-22 | 20261022800424 | Organization of Investor Relations Event | 기업설명회(IR)개최(안내공시) | 동아에스티 |
2026-10-22 | 20261022800421 | Prior Notice on Disclosure of Final Earnings | 결산실적공시예고(안내공시) | 동아에스티 |
2026-10-22 | 20261022000332 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 동아제약 |
2026-08-20 | 20260820000424 | [Corrected description]Semi-annual Report (2026.06) | [기재정정]반기보고서 (2026.06) | 동아에스티 |
2026-08-14 | 20260814003525 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | 동아에스티 |
Source & Disclaimer
source_url: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001313 | verified_at: 2026-11-01T02:26:13.029Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.